NCT06445036|Not Yet Recruiting
Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism
THYPARS
Loading search results
THYPARS
Sponsor study identifier
observational
1,000
1 country
1
Study Start
February 27, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
July 27, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 27, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Observational, multicenter, national, cross-sectional study aiming to describe the epidemiological clinical, biological and therapeutic profile of patients suffering from defect in secretion (hypoparathyroidism) or action (pseudo-hypoparathyroidism) of parathyroid hormone.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 27, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 31, 2024
Actual (reported)June 6, 2024
Actual (reported)February 27, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
July 27, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
July 27, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Incidence of primary hypoparathyroidism
Number of subjects with primary hypoparathyroidism at enrollment
Day 1
Incidence of congenital hypoparathyroidism
Number of subjects with congenital hypoparathyroidism at enrollment
Day 1
Incidence of acquired hypoparathyroidism
Number of subjects with acquired hypoparathyroidism at enrollment
Day 1
Incidence of secondary hypoparathyroidism
Number of subjects with secondary hypoparathyroidism at enrollment
Day 1
Consecutive patients suffering from hypoparathyroidism and/or pseudo hypoparathyroidism
Société Tunisienne D'endocrinologie De Diabétologie Et Des Maladies Métaboliques
Sfax, Tunisia, 3000, Tunisia
Nabila Rekik Mejdoub, MD
Société Tunisienne D'endocrinologie De Diabétologie Et Des Maladies Métaboliques
First Submitted
May 31, 2024
First Posted
June 6, 2024
Study Start
February 27, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
July 27, 2025
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
July 27, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
February 21, 2025
Record last verified: 2025-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: